Literature DB >> 16080309

Diagnosis and management of neck metastases from an unknown primary.

L Calabrese1, B A Jereczek-Fossa, J Jassem, A Rocca, R Bruschini, R Orecchia, F Chiesa.   

Abstract

Neck lymph node metastases from occult primary constitute about 5%-10% of all patients with carcinoma of unknown primary site. Metastases in the upper and middle neck (levels I-II-III-V) are generally attributed to head and neck cancers, whereas the lower neck (level IV) involvement is often associated with primaries below the clavicles. Diagnostic procedures include a careful clinical evaluation and a fiberoptic endoscopic examination of the head and neck mucosa, biopsies from all suspicious sites or blindly from the sites of possible origin of the primary, computerized tomography scan, and magnetic resonance. The most frequent histological finding is Squamous Cell Carcinoma, particularly when the upper neck is involved. In these cases, a systematic tonsillectomy in the absence of suspicious lesions is discussed since up to 25% of primary tumours can be detected in this site. Thoracic, and abdominal primaries (especially from lung, oesophagus, stomach, ovary or pancreas) should be sought in the case of adenocarcinoma and involvement of the lower neck. Positron emission tomography with fluoro-2-deoxy-D-glucose allows detection of primary tumour in about 25% of cases, but this procedure is still considered investigational. Therapeutic approaches include surgery (neck dissection), with or without post-operative radiotherapy, radiotherapy alone and radiotherapy followed by surgery as reported by several guide-lines. In early stages (N1), neck dissection and radiotherapy seem to have similar efficacy, whereas more advanced cases (N2, N3) require combined approaches. The extent of radiotherapy (irradiation of bilateral neck and mucosa versus ipsilateral neck radiotherapy) remains debatable. A potential benefit from extensive radiotherapy should be weighed against its acute and late morbidity and difficulties in re-irradiation in the case of subsequent primary emergence. The role of other methods, such as chemotherapy and hyperthermia, remains to be determined.

Entities:  

Mesh:

Year:  2005        PMID: 16080309      PMCID: PMC2639847     

Source DB:  PubMed          Journal:  Acta Otorhinolaryngol Ital        ISSN: 0392-100X            Impact factor:   2.124


  91 in total

1.  Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck.

Authors:  Jay S Cooper; Thomas F Pajak; Arlene A Forastiere; John Jacobs; Bruce H Campbell; Scott B Saxman; Julie A Kish; Harold E Kim; Anthony J Cmelak; Marvin Rotman; Mitchell Machtay; John F Ensley; K S Clifford Chao; Christopher J Schultz; Nancy Lee; Karen K Fu
Journal:  N Engl J Med       Date:  2004-05-06       Impact factor: 91.245

2.  Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.

Authors:  Jacques Bernier; Christian Domenge; Mahmut Ozsahin; Katarzyna Matuszewska; Jean-Louis Lefèbvre; Richard H Greiner; Jordi Giralt; Philippe Maingon; Frédéric Rolland; Michel Bolla; Francesco Cognetti; Jean Bourhis; Anne Kirkpatrick; Martine van Glabbeke
Journal:  N Engl J Med       Date:  2004-05-06       Impact factor: 91.245

3.  Diagnosis and management of carcinoma of unknown primary in the head and neck.

Authors:  Wolfgang J Issing; Behsad Taleban; Stefan Tauber
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-04-09       Impact factor: 2.503

4.  Cervical metastases from an unknown primary tumor.

Authors:  P J Fitzpatrick; J F Kotalik
Journal:  Radiology       Date:  1974-03       Impact factor: 11.105

5.  Cervical lymph node metastasis: unknown primary cancer.

Authors:  R H Jesse; C A Perez; G H Fletcher
Journal:  Cancer       Date:  1973-04       Impact factor: 6.860

6.  Bilateral synchronous tonsillar carcinoma in cervical cancer of unknown primary site (CUPS).

Authors:  Ilkay Kazak; Andreas Haisch; Sergije Jovanovic
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-05-09       Impact factor: 2.503

Review 7.  Radiotherapy-induced thyroid disorders.

Authors:  Barbara A Jereczek-Fossa; Daniela Alterio; Jacek Jassem; Bianca Gibelli; Nicoletta Tradati; Roberto Orecchia
Journal:  Cancer Treat Rev       Date:  2004-06       Impact factor: 12.111

Review 8.  The unknown biology of the unknown primary tumour: a literature review.

Authors:  A J van de Wouw; R L H Jansen; E J M Speel; H F P Hillen
Journal:  Ann Oncol       Date:  2003-02       Impact factor: 32.976

9.  Lymph node metastasis of squamous cell carcinoma from an unknown primary: impact of positron emission tomography.

Authors:  Sandro J Stoeckli; Katarzyna Mosna-Firlejczyk; Gerhard W Goerres
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-12-17       Impact factor: 9.236

Review 10.  Cervical lymph node metastases of squamous cell carcinoma from an unknown primary.

Authors:  Barbara A Jereczek-Fossa; Jacek Jassem; Roberto Orecchia
Journal:  Cancer Treat Rev       Date:  2004-04       Impact factor: 12.111

View more
  11 in total

1.  Management of neck metastases of unknown primary origin united in two European centers.

Authors:  Jos Straetmans; Julia Vent; Martin Lacko; Ernst-Jan Speel; Christian Huebbers; Robert Semrau; Frank Hoebers; Zlatan Mujagic; Jens-Peter Klussmann; Simon F Preuss; Bernd Kremer
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-11       Impact factor: 2.503

2.  Role of 18F-FDG PET in detecting primary site in the patient with primary unknown carcinoma.

Authors:  Kenichiro Yabuki; Mamoru Tsukuda; Choichi Horiuchi; Takahide Taguchi; Goshi Nishimura
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-09-03       Impact factor: 2.503

3.  Occult Primary with Cervical Secondary-Role of CT Scan and Evaluation Under Anesthesia.

Authors:  Ila B Upadhya; Jay Suratwala
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2017-07-20

Review 4.  Role of (18)F-FDG PET/CT in pre and post treatment evaluation in head and neck carcinoma.

Authors:  Bundhit Tantiwongkosi; Fang Yu; Anand Kanard; Frank R Miller
Journal:  World J Radiol       Date:  2014-05-28

5.  Diagnosis and treatment of a neck node swelling suspicious for a malignancy: an algorithmic approach.

Authors:  A J M Balm; M L F van Velthuysen; F J P Hoebers; W V Vogel; M W M van den Brekel
Journal:  Int J Surg Oncol       Date:  2010-05-30

6.  Contrast-enhanced [18F] fluorodeoxyglucose-positron emission tomography-computed tomography as an initial imaging modality in patients presenting with metastatic malignancy of undefined primary origin.

Authors:  Avani Jain; Madhur Kumar Srivastava; Alok Suresh Pawaskar; Simon Shelley; Indirani Elangovan; Hasmukh Jain; Somnath Pandey; Shilpa Kalal; Jaykanth Amalachandran
Journal:  Indian J Nucl Med       Date:  2015 Jul-Sep

7.  Squamous cell carcinoma metastatic to cervical lymph nodes from unknown primary origin: the impact of chemoradiotherapy.

Authors:  Hany Eldeeb; Rasha Hamdy Hamed
Journal:  Chin J Cancer       Date:  2012-06-06

8.  Management delays in patients with squamous cell cancer of neck node(s) and unknown primary site: a retrospective cohort study.

Authors:  Kevin Martell; Joanna Mackenzie; Warren Kerney; Harold Yeehau Lau
Journal:  J Otolaryngol Head Neck Surg       Date:  2017-05-08

9.  Deep neck abscess as the predominant initial presentation of carcinoma of unknown primary: A case report.

Authors:  Wei-Ting Chen; Jui-Wen Lee; Kun-Wei Hsieh; Rong-Feng Chen
Journal:  Oncol Lett       Date:  2014-01-28       Impact factor: 2.967

Review 10.  Synchronous bilateral tonsil carcinoma: case presentation and review of the literature.

Authors:  M-N Theodoraki; J A Veit; T K Hoffmann; J Greve
Journal:  Infect Agent Cancer       Date:  2017-06-26       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.